Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Gastroenterol ; 47(5): 519-30, 2012 May.
Article in English | MEDLINE | ID: mdl-22200942

ABSTRACT

BACKGROUND: Neutrophil gelatinase-associated lipocalin (NGAL) is a multi-potent 25-kDa protein mainly secreted by neutrophils. In inflammatory bowel disease (IBD), overexpression of NGAL in colon epithelium has been previously shown. This is the first study analyzing serum and urinary NGAL levels in IBD patients, with regard to specific characteristics of patients and disease. METHODS: Serum and urinary NGAL levels were determined in 181 patients with IBD, 93 with ulcerative colitis (UC), and 88 with Crohn's disease (CD), 82 healthy controls (HC), and 41 patients with irritable bowel syndrome (IBS). RESULTS: Serum NGAL levels were elevated in IBD patients (88.19 ± 40.75 ng/mL) compared with either HC (60.06 ± 24.18 ng/mL) or IBS patients (60.80 ± 20.30 ng/mL), P < 0.0001. No significant difference was shown between UC (86.62 ± 35.40 ng/mL) and CD (89.92 ± 46.05 ng/mL). Significantly higher levels of serum NGAL were observed in patients with active (120.1 ± 38.46) versus inactive IBD (61.58 ± 15.98), P < 0.0001. Serum NGAL displayed a strong ability to distinguish active IBD from inactive disease, healthy controls, or IBS patients with a sensitivity of 100, 95, and 95% and a specificity of 68, 83, and 79%, respectively, performing better than erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) in the assessment of disease activity in both UC and CD. Urinary NGAL levels showed neither significant difference among patients and controls nor correlation with disease activity. CONCLUSIONS: Serum NGAL is elevated particularly in active IBD and correlates with established markers of inflammation and disease activity, implicating its role in the pathophysiology of IBD.


Subject(s)
Acute-Phase Proteins/physiology , Inflammatory Bowel Diseases/physiopathology , Lipocalins/physiology , Proto-Oncogene Proteins/physiology , Acute-Phase Proteins/urine , Adolescent , Adult , Aged , Biomarkers/blood , Biomarkers/urine , C-Reactive Protein/metabolism , Case-Control Studies , Colitis, Ulcerative/diagnosis , Colitis, Ulcerative/metabolism , Colitis, Ulcerative/physiopathology , Crohn Disease/diagnosis , Crohn Disease/metabolism , Crohn Disease/physiopathology , Diagnosis, Differential , Female , Humans , Inflammatory Bowel Diseases/diagnosis , Inflammatory Bowel Diseases/metabolism , Irritable Bowel Syndrome/diagnosis , Irritable Bowel Syndrome/metabolism , Irritable Bowel Syndrome/physiopathology , Lipocalin-2 , Lipocalins/blood , Lipocalins/urine , Male , Middle Aged , Proto-Oncogene Proteins/blood , Proto-Oncogene Proteins/urine , Sensitivity and Specificity , Severity of Illness Index , Young Adult
2.
Eur J Echocardiogr ; 4(1): 73-5, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12565067

ABSTRACT

The case of a 72-year old patient with acute heart failure due to thrombosis of the mechanical mitral prosthesis is presented. The diagnosis was made by transthoracic echocardiography. The patient refused reoperation, and systemic thrombolysis was administered. After thrombolytic infusion we observe the disappearance of the echocardiographic signs of thrombosis, with concomitant improvement of symptoms.


Subject(s)
Fibrinolytic Agents/therapeutic use , Heart Valve Prosthesis , Mitral Valve/diagnostic imaging , Thrombolytic Therapy , Thrombosis/diagnostic imaging , Tissue Plasminogen Activator/therapeutic use , Acute Disease , Aged , Echocardiography/methods , Fatal Outcome , Humans , Male , Prosthesis Failure , Thrombosis/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...